0001209191-15-003771.txt : 20150112
0001209191-15-003771.hdr.sgml : 20150112
20150112181755
ACCESSION NUMBER: 0001209191-15-003771
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150108
FILED AS OF DATE: 20150112
DATE AS OF CHANGE: 20150112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NUVASIVE INC
CENTRAL INDEX KEY: 0001142596
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330768598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7475 LUSK BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 909-1800
MAIL ADDRESS:
STREET 1: 7475 LUSK BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lukianov Alexis V
CENTRAL INDEX KEY: 0001289410
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50744
FILM NUMBER: 15522913
MAIL ADDRESS:
STREET 1: 7475 LUSK BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-01-08
0
0001142596
NUVASIVE INC
NUVA
0001289410
Lukianov Alexis V
7475 LUSK BLVD
SAN DIEGO
CA
92121
1
1
0
0
Chairman & CEO
Common Stock
2015-01-08
4
M
0
18750
18.31
A
186181
D
Common Stock
2015-01-08
4
F
0
11298
50.39
D
174883
D
Common Stock
2015-01-12
4
S
0
7452
49.6871
D
167431
D
Employee Stock Option (Right to Buy)
18.31
2015-01-08
4
M
0
18750
0.00
A
2016-01-03
Common Stock
18750
0
D
Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on November 15, 2014, which is intended to comply with Rule 10b5-1.
Weighted average from 73 transactions with prices ranging from $49.4200 to $50.0750. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
The option, representing a right to purchase a total of 244,539 shares, became exercisable as follows: 25% of the shares vested on January 3, 2007; the remaining shares vested monthly thereafter so that all shares were fully vested as of January 3, 2010, subject to continued employment through each vesting period.
/s/ Jason M. Hannon, Attorney-in-Fact for Alexis V. Lukianov
2015-01-12